MORGAN STANLEY PLC/CALL/MERCK & CO./165/0.1/19.12.25 Share Price

Warrant

DE000ME8HEC5

Real-time Bid/Ask 11:30:22 21/05/2024 am IST
0.45 EUR / 0.47 EUR -4.17% Intraday chart for MORGAN STANLEY PLC/CALL/MERCK & CO./165/0.1/19.12.25
Current month-5.88%
1 month+2.13%
Date Price Change
20/24/20 0.48 +4.35%
17/24/17 0.46 -2.13%
16/24/16 0.47 +4.44%
15/24/15 0.45 +9.76%
14/24/14 0.41 0.00%

Delayed Quote Börse Stuttgart

Last update May 20, 2024 at 09:22 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN ME8HEC
ISINDE000ME8HEC5
Date issued 09/02/2024
Strike 165 $
Maturity 19/12/2025 (578 Days)
Parity 10 : 1
Emission price 0.42
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.65
Lowest since issue 0.37
Spread 0.02
Spread %4.26%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131 USD
Average target price
141.6 USD
Spread / Average Target
+8.13%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW